Inhibitory potentials of phytocompounds from Ocimum gratissimum against anti-apoptotic BCL-2 proteins associated with cancer: an integrated computational study

References

• Anantram A, Kundaikar H, Degani M, et al. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity. J Biomol Struct Dynami. 2019;37(12):3109–3121.
   PubMed Web of Science ®Google Scholar
• Petros AM, Medek A, Nettesheim DG, et al. Solution structure of the antiapoptotic protein bcl-2. Proc Nat Acad Sci. 2001;98(6):3012–3017.
   PubMed Web of Science ®Google Scholar
• Ku B, Liang C, Jung JU, et al. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res. 2011;21(4):627–641.
   PubMed Web of Science ®Google Scholar
• Adewole KE, Ishola AA. Phytosterols and triterpenes from Morinda lucida Benth (Rubiaceae) as potential inhibitors of anti-apoptotic BCL-XL, BCL-2, and MCL-1: an in-silico study. J Recept Signal Transduct. 2019;39(1):87–97.
   PubMed Web of Science ®Google Scholar
• Wilson WH, O’Connor OA, Czuczman MS, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11(12):1149–1159.
   PubMed Web of Science ®Google Scholar
• Souers AJ, Leverson JD, Boghaert ER, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19(2):202–208.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Fairbrother WJ, Leverson JD, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov. 2017;16(4):273–284.
   PubMed Web of Science ®Google Scholar
• Nweze EI, Eze EE. Justification for the use of Ocimum gratissimum L in herbal medicine and its interaction with disc antibiotics. BMC Complement Altern Med. 2009;9(1):1–6.
   Google Scholar
• Ojo OA, Ojo AB, Oyinloye BE, et al. Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats. BMC Complement Altern Med. 2019;19(1):1–10.
   Google Scholar
• Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res. 2006;50(2):144–151.
   PubMed Web of Science ®Google Scholar
• Priyanka C, Shivika S, Vikas S. Ocimum gratissimum: a review on ethnomedicinal properties, phytochemical constituents, and pharmacological profile. In: Kumar N, editor. Biotechnological Approaches for Medicinal and Aromatic Plants: conservation, Genetic Improvement and Utilization. Springer Singapore: Singapore; 2018. p. 251–270.
   Google Scholar
• Ekunwe SI, Thomas MS, Luo X, et al. Potential cancer-fighting Ocimum gratissimum (OG) leaf extracts: increased anti-proliferation activity of partially purified fractions and their spectral fingerprints. Ethn Dis. 2010;20(1):12.
   Web of Science ®Google Scholar
• Nangia-Makker P, Raz T, Tait L, et al. Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. Cancer Biol Ther. 2013;14(5):417–427.
   PubMed Web of Science ®Google Scholar
• Huang -C-C, Hwang J-M, Tsai J-H, et al. Aqueous Ocimum gratissimum extract induces cell apoptosis in human hepatocellular carcinoma cells. Int J Med Sci. 2020;17(3):338.
   Web of Science ®Google Scholar
• Gupta S, Prakash J, Srivastava S. Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant; 2002.
   Google Scholar
• Do Nascimento Silva MK, Carvalho VRDA, Matias EFF. Chemical profile of essential oil of Ocimum gratissimum L. and evaluation of antibacterial and drug resistance-modifying activity by gaseous contact method. Pharmacogn J. 2016;8(1):19.
   Google Scholar
• Selvaraju R, Sakuntala P, Jaleeli KA. GC–MS and FTIR Analysis of Chemical Compounds in Ocimum Gratissimum Plant. Biophysics. 2021;66(3):401–408.
   Google Scholar
• Matasyoh LG, Matasyoh JC, Wachira FN, et al. Chemical composition and antimicrobial activity of the essential oil of Ocimum gratissimum L. growing in Eastern Kenya. Afr J Biotechnol. 2007;6(6).5.
   Google Scholar
• Kpadonou Kpoviessi BG, Ladekan EY, Kpoviessi DSS, et al. Chemical variation of essential oil constituents of Ocimum gratissimum L. from Benin, and impact on antimicrobial properties and toxicity against Artemia salina Leach. Chem Biodivers. 2012;9(1):139–150.
   Web of Science ®Google Scholar
• Fokou JBH, Dongmo PM, Boyom FF, et al. Antioxidant and antifungal activities of the essential oils of Ocimum gratissimum from Yaoundé and Dschang (Cameroon). J Pharm Pharmacol. 2014;2:257–268.
   Google Scholar
• Melo RS, Albuquerque Azevedo ÁM, Gomes Pereira AM, et al. Chemical composition and antimicrobial effectiveness of Ocimum gratissimum L. essential oil against multidrug-resistant isolates of Staphylococcus aureus and Escherichia coli. Molecules. 2019;24(21):3864.
   Web of Science ®Google Scholar
• Runyoro D, Ngassapa O, Vagionas K, et al. Chemical composition and antimicrobial activity of the essential oils of four Ocimum species growing in Tanzania. Food Chem. 2010;119(1):311–316.
   Web of Science ®Google Scholar
• Joshi R. Chemical composition, in vitro antimicrobial and antioxidant activities of the essential oils of Ocimum gratissimum, O. sanctum and their major constituents. Indian J Pharm Sci. 2013;75(4):457.
   PubMed Web of Science ®Google Scholar
• Katara A, Pradhan CK, Singh P, et al. Volatile Constituents and Antimicrobial Activity of Aerial parts of Ocimum gratissimum Linn. J Essential Oil Bearing Plant. 2013;16(2):283–288.
   Web of Science ®Google Scholar
• Prabhu KS, Lobo R, Shirwaikar AA, et al. Ocimum gratissimum: a review of its chemical, pharmacological and ethnomedicinal properties. Open Complement Med J. 2009;1(1):1–15.
   Google Scholar
• Monga S, Dhanwal P, Kumar R, et al. Pharmacological and physico-chemical properties of Tulsi (Ocimum gratissimum L.): an updated review. Pharma Innovation. 2017;6(4, Part C):181.
   Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, et al. Open Babel: an open chemical toolbox. J Cheminform. 2011;3(1):33.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
   PubMed Web of Science ®Google Scholar
• Phillips JC, Braun R, Wang W, et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26(16):1781–1802.
   PubMed Web of Science ®Google Scholar
• Lee J, Cheng X, Swails JM, et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem Theory Comput. 2016;12(1):405–413.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Brooks CL, Mackerell AD, et al. CHARMM: the biomolecular simulation program. J Comput Chem. 2009;30(10):1545–1614.
   PubMed Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1):33–38.
   PubMedGoogle Scholar
• Suomivuori C-M, Latorraca NR, Wingler LM, et al. Molecular mechanism of biased signaling in a prototypical G protein–coupled receptor. Science. 2020;367(6480):881–887.
   Web of Science ®Google Scholar
• Salentin S, Schreiber S, Haupt VJ, et al. PLIP: fully automated protein–ligand interaction profiler. Nucleic Acids Res. 2015;43(W1):W443–W447.
   PubMed Web of Science ®Google Scholar
• Nickel J, Gohlke B-O, Erehman J, et al. SuperPred: update on drug classification and target prediction. Nucleic Acids Res. 2014;42(W1):W26–W31.
   PubMed Web of Science ®Google Scholar
• Cheng F, Li W, Zhou Y, et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52(11):3099–3105.
   PubMed Web of Science ®Google Scholar
• Dong J, Wang -N-N, Yao Z-J, et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10(1):1–11.
   PubMedGoogle Scholar
• Shamas-Din A, Kale J, Leber B, et al. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol. 2013;5(4):a008714.
   PubMed Web of Science ®Google Scholar
• Timucin AC, Basaga H, Kutuk O. Selective targeting of antiapoptotic BCL‐2 proteins in cancer. Med Res Rev. 2019;39(1):146–175.
   Web of Science ®Google Scholar
• Ramos J, Muthukumaran J, Freire F, et al. Shedding light on the interaction of human anti-apoptotic Bcl-2 protein with ligands through biophysical and in silico studies. Int J Mol Sci. 2019;20(4):860.
   Web of Science ®Google Scholar
• Sleebs BE, Kersten WJA, Kulasegaram S, et al. Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-X L. J Med Chem. 2013;56(13):5514–5540.
   Web of Science ®Google Scholar
• Priya P, Maity A, Majumdar S, et al. Interactions between Bcl-xl and its inhibitors: insights into ligand design from molecular dynamics simulation. J Mol Graphics Modell. 2015;59:1–13.
   Google Scholar
• Seo DY, Lee SR, Heo J-W, et al. Ursolic acid in health and disease. Korean J Physiol Pharmacol. 2018;22(3):235.
   PubMed Web of Science ®Google Scholar
• Kassi E, Sourlingas TG, Spiliotaki M, et al. Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest. 2009;27(7):723–733.
   PubMed Web of Science ®Google Scholar
• Teoh PL, Cheng AYF, Liau M, et al. Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts. Pharm Biol. 2017;55(1):394–401.
   PubMed Web of Science ®Google Scholar
• Moon D-O, Lee K-J, Choi YH, et al. β-Sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells. Int Immunopharmacol. 2007;7(8):1044–1053.
   PubMed Web of Science ®Google Scholar
• Park C, Moon D-O, Rhu C-H, et al. β-Sitosterol induces anti-proliferation and apoptosis in human leukemic U937 cells through activation of caspase-3 and induction of Bax/Bcl-2 ratio. Biol Pharm Bull. 2007;30(7):1317–1323.
   Web of Science ®Google Scholar
• Niu H, Li X, Yang A, et al. Cycloartenol exerts anti-proliferative effects on Glioma U87 cells via induction of cell cycle arrest and p38 MAPK-mediated apoptosis. J BUON. 2018;23. 1840–1845.
   PubMed Web of Science ®Google Scholar
• Li K, Yuan D, Yan R, et al. Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway. J BUON. 2018;23(5): 1420–1425.
   PubMed Web of Science ®Google Scholar
• Ganai SA, Sheikh FA, Baba ZA, et al. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated. Phytother Res. 2021;35(7):3509–3532.
   Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.
   PubMed Web of Science ®Google Scholar
• Huang L, Jin K, Lan H. Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase. Oncol Lett. 2019;17(4):3842–3850.
   PubMed Web of Science ®Google Scholar
• Cook MT, Mafuvadze B, BESCH-WILLIFORD C, et al. Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7, 12-dimethylbenz (a) anthracene-induced mammary tumors in Sprague-Dawley rats. Oncol Rep. 2016;35(2):825–832.
   PubMed Web of Science ®Google Scholar
• Sinha S, Wang SM. Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation. Comput Struct Biotechnol J. 2020;18:723–736.
   PubMed Web of Science ®Google Scholar
• Dong Y-W, Liao M-L, Meng X-L, et al. Structural flexibility and protein adaptation to temperature: molecular dynamics analysis of malate dehydrogenases of marine molluscs. Proc Nat Acad Sci. 2018;115(6):1274–1279.
   PubMed Web of Science ®Google Scholar
• Cheng X, Ivanov I. Molecular dynamics. Comput Toxicol. 2012;2012:243–285.
   Google Scholar
• Perez A, Morrone JA, Simmerling C, et al. Advances in free-energy-based simulations of protein folding and ligand binding. Curr Opin Struct Biol. 2016;36:25–31.
   PubMed Web of Science ®Google Scholar
• Kollman PA, Massova I, Reyes C, et al. Calculating Structures and Free Energies of Complex Molecules:  combining Molecular Mechanics and Continuum Models. Acc Chem Res. 2000;33(12):889–897.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1–3):3–25.
   Web of Science ®Google Scholar
• Elipilla P. Designing, molecular docking and toxicity studies of novel plasmepsin II inhibitors. Eur J Biotechnol Biosci. 2015;3:27–30.
   Google Scholar
• Wang -N-N, Huang C, Dong J, et al. Predicting human intestinal absorption with modified random forest approach: a comprehensive evaluation of molecular representation, unbalanced data, and applicability domain issues. RSC Adv. 2017;7(31):19007–19018.
   Web of Science ®Google Scholar
• Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clin Pharmacokinet. 2003;42(1):59–98.
   PubMed Web of Science ®Google Scholar
• Kratz JM, Grienke U, Scheel O, et al. Natural products modulating the hERG channel: heartaches and hope. Nat Prod Rep. 2017;34(8):957–980.
   PubMed Web of Science ®Google Scholar
• Mulliner D, Schmidt F, Stolte M, et al. Computational models for human and animal hepatotoxicity with a global application scope. Chem Res Toxicol. 2016;29(5):757–767.
   PubMed Web of Science ®Google Scholar
• Rostkowski M, Spjuth O, Rydberg P. WhichCyp: prediction of cytochromes P450 inhibition. Bioinformatics. 2013;29(16):2051–2052.
   PubMed Web of Science ®Google Scholar
• Zhu H, Martin TM, Ye L, et al. Quantitative structure− activity relationship modeling of rat acute toxicity by oral exposure. Chem Res Toxicol. 2009;22(12):1913–1921.
   Web of Science ®Google Scholar
• O’Boyle NM, Sayle RA. Comparing structural fingerprints using a literature-based similarity benchmark. J Cheminform. 2016;8(1):1–14.
   Google Scholar